Big Changes in CLL Treatment Mean Opportunities for Patients

Dr. John Pagel, from the Seattle Cancer Care Alliance, details important advances that signal a changing treatment landscape in CLL with new options for patients. Pagel explains some of the new drug therapies, including insights from ASH 2012, that may mean a move away from chemotherapy for some patients.